Latest advances on regiospecif ic microwave-assisted synthesis of novel purine derivatives as antitumor agents

Expert Opinion on Therapeutic Patents

Volumn 18, Issue 2, 2008, Pages 211-222

  Conejo García, Ana ^a   Gallo, Miguel A ^a   Espinosa, Antonio ^a   Campos, Joaquín M ^a  

^a Facultad de Farmacia   (Spain)

Author keywords

6 substituted purine; Antitumor compound; Apoptosis; MCF 7; Microwave

Indexed keywords

3,4 DIHYDRO 2H 1,5 BENZOXATHIEPIN 3 OL; 6 O CYCLOHEXYLMETHYLGUANINE; 9 (2,3 DIHYDRO 1,4 BENZOXANTHIIN 3 YLMETHYL) 9H PURINE DERIVATIVE; 9 (2,3 DIHYDRO 5H 1,4 BENZODIOXEPIN 3 YL) 7H PURINE DERIVATIVE; 9 (2,3 DIHYDRO 5H 1,4 BENZODIOXEPIN 3 YL) 9H PURINE DERIVATIVE; ANTINEOPLASTIC AGENT; FLUOROURACIL; PURINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE PHASE; CELL STRAIN MCF 7; DRUG ISOLATION; DRUG MANUFACTURE; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; IC 50; MICROWAVE RADIATION; STRUCTURE ACTIVITY RELATION;

EID: 40749147619     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.18.2.211     Document Type: Article

References (54)

1. Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 1995;308:697-711
2. Monaco EA III, Beaman-Hall CM, Mathur A, Vallano ML. Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons. Biochem Pharmacol 2004;67:1947-64
3. Nurse P, Masui Y, Hartwell L. Understanding the cell cycle. Nature Med 1998;4:1103-6
4. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 1996;68:67-108
5. Chevalier S, Blow JJ. Cell cycle control of replication initiation in eukaryotes. Curr Opin Cel Biol 1996;8:815-21
6. Toogood PL. Progress toward the development of agents to modulate the cycle. Curr Opin Chem Biol 2002;6:472-8
7. 6-cyclohexylmethylguanine derivatives potent inhibitors of cyclin-dependent kinases 1 and 2. J Med Chem 2004;47:3710-22
8. Sielecki TM, Boylan JF, Benfield PA, Trainor GL. Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation. J Med Chem 2000;43:1-18
9. Knockaert M, Greegard P, Meijer L. Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol Sci 2002;23:417-25
10. Arris CE, Boyle T, Calvert H, et al. Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. J Med Chem 2000;43:2797-804
11. Marchal JA, Núñez MC, Suárez I, et al. A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells. Breast Cancer Res Tr 2007;105:237-46
12. Núñez MC, Pavani MG, Díaz-Gavilán M, et al. Synthesis and anticancer activity studies of novel 1-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl) uracil and (6′ -substituted)-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or 9H-purines. Tetrahedron 2006;62:11724-33
13. Conejo-García A, Núñez MC, Marchal JA, et al. Regioespecific microwave-assisted synthesis and cytotoxic activity against human breast cancer cells of (RS)-6-substituted-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or -9H-purines. Eur J Med Chem 2007; published online 25 October 2007, doi:10.1016/ j.ejmech.2007.10.025
14. Saniger E, Campos JM, Entrena A, et al. Medium benzene-fused oxacycles with the 5-fluorouracil moiety: synthesis, antiproliferative activities and apoptosis induction in breast cancer cells. Tetrahedron 2003;59:5457-67
15. Guillaumet G. Comprehensive Heterocyclic Chemistry II (Volume 6), Pergamon, Oxford; 1996
16. Quaglia W, Pigini M, Piergentili A, et al. Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes. J Med Chem 1999;42:2961-68 and references cited therein
17. Pallvicini M, Fumagalli L, Gobbi M, et al. QSAR study for a novel series of ortho disubstituted phenoxy analogues of alpha1-adrenoceptor antagonist WB4101. Eur J Med Chem 2006;41:1025-40
18. Birch AM, Bradley PA, Gill JC, Kerrigan F, Needham PL. N-Substituted (2,3-dihydro-1,4-benzodioxin-2-yl) methylamine derivatives as D(2) antagonists/5-HT(1A) partial agonists with potential as atypical antipsychotic agents. J Med Chem 1999;42:3342-55 and references cited therein
19. Satoh Y, Powers C, Toledo LM, Kowalski TJ, Peters PA, Kimble EF. Derivatives of 2- N-(Aminocarbonyl)-N-hydroxyamino] methyl]-1,4-benzodioxan as orally active 5-lipoxygenase inhibitors. J Med Chem 1995;38:68-75
20. Fukuyama Y, Hasegawa T, Toda M, Kodama M, Okazaki H. Structures of americanol A and isoamericanol A having a neurotrophic property from the seeds of Phytolacca Americana. Chem Pharm Bull 1992;40:252-4
21. Malet-Martino M, Jolimaitre P, Martino R. The prodrugs of 5-fluorouracil. Curr Med Chem Anticancer Agents 2002;2:267-310
22. Ozaki S. Synthesis and antitumor activity of 5-fluorouracil derivatives. Med Res Rev 1996;16:51-86
23. 3 hybridized carbon bonded to oxygen and to nitrogen are known as O,N-acetals or hemiaminals
24. Campos J, Saniger E, Marchal JA, et al. New medium oxacyclic O,N-acetals and related open analogues: biological activities. Curr Med Chem 2005;12:1423-38
25. Díaz-Gavilán M, Conejo-García A, Cruz-López O, et al. Synthesis and Anticancer Activity of (RS)-9-(2,3-Dihydro-1,4-Benzoxathiin-3-ylmethyl)-9H-Purines. Chem Med Chem 2007; published online: 19 November 2007, doi: 10.1002/ cmdc.200700180
26. Vorbrüggen H, Bennua B. Nucleoside syntheses. XXV. A new simplified nucleoside synthesis. Chem Ber 1981;114:1279-86
27. Laufer SA, Domeyer DM, Scior TRF, Albrecht W, Hauser DRJ. Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors. J Med Chem 2005;48:710-22
28. Griffin RJ, Calvert AM, Curtin NJ, et al. Preparation of cyclin dependent kinase inhibiting purine derivatives. WO9902162 (1999)
29. Kappe CO. Synthetic methods. Controlled microwave heating in modern organic synthesis. Angew Chem Int Ed 2004;43:6250-84
30. Hayes BL. Recent advances in microwave-assisted synthesis. Aldrichim Acta 2004;37:66-77
31. De la Hoz A, Díaz-Ortiz A, Moreno A. Microwaves in organic synthesis. Thermal and non-thermal microwave effects. Chem Soc Rev 2005; 34:164-78
32. Kappe CO, Stadler A. Microwaves in Organic and Medicinal Chemistry. Wiley-VCH, Weinheim; 2005
33. Lidström P, Tierney JP. Microwave-assisted Organic Synthesis. Blackwell, Oxford; 2005
34. Loupy A. Microwaves in Organic Synthesis. Wiley-VCH, Weinheim; 2002
35. Hayes BL. Microwave Synthesis: Chemistry at the Speed of Light. CEM, Matthews, NC; 2002
36. Al-Obeidi F, Austin RE, Okonya JF, Bond DRS. Microwave-assisted solid-phase synthesis (MASS): parallel and combinatorial chemical library synthesis. Mini Rev Med Chem 2003;3:449-60
37. Kappe CO, Dallinger D. The impact of microwave synthesis on drug discovery. Nat Rev Drug Discov 2006;5:51-63
38. Núñez MC, Rodríguez-Serrano F, Marchal JA, et al. 6′-Chloro-7- or 9-(2,3-dihydro-5H-4,1-benzoxathiepin-3-yl)-7H- or 9H-purines and their corresponding sulfones as a new family of cytotoxic drugs. Tetrahedron 2007;63:183-90
39. Villalobos M, Olea N, Brotons JA, Olea-Serrano MF, Ruiz de Almodóvar JM, Pedraza, V. The E-screen assay: a comparison of different MCF7 cell stocks. Environ Health Persp 1995;103:844-9
40. 1-arrest, and apoptosis in MCF-7 human breast cancer cells by novel highly lipophilic 5-fluorouracil derivatives. Invest New Drugs 2004;22:379-89
41. Cabiddu S, Melis S, Sotgiu F, Cerioni G. Heterocyclic compounds studies; synthesis of 1,5-benzoxathiepines. Phosphorus Sulfur 1983;14:151-6
42. Rosnati V, De Marchi F. Chemical and spectroscopic properties of 2-formyl-1,4-benzodioxane and 3-keto-3,4-dihydro-2H-1,5-benzodioxepin. Tetrahedron 1962;18:289-98
43. Tsai CS, Shah US, Bhargava HB, Zaylskie RG, Sherlver WH. Synthesis of 2-dialkylaminomethyl-1,4-benzoxathians. J Pharm Sciences 1972;61:228-31
44. Saniger E, Campos JM, Entrena A, et al. Neighbouring-group participation as the key step in the reactivity of acyclic and cyclic salicyl-derived O,O-acetals with 5-fluorouracil. Antiproliferative activity, cell cycle dysregulation and apoptotic induction of new O,N-acetals against breast cancer cells. Tetrahedron 2003;59:8017-26
45. For an extensive treatment of sulfur as a neighbouring group, see: Capon B, McManus SP. Neighboring Group Participation. Plenum Press, New York; 1976
46. Yoshimura Y, Kuze T, Ueno M, et al. A practical synthesis of 4′-thioribonucleosides. Tetrahedron Lett 2006;47:591-4
47. Hughes NA, Kuhajda K-M, Miljkovic DA. New syntheses of methyl 5-thio-β-D-arabinopyranoside and (+)-biotin. Carbohydr Res 1994;257:299-304
48. Altenbach H-J, Merhof GF. Synthesis of 1-deoxy-4-thio-L-ribose starting from D-arabitol. Tetrahedron Asymmetr 1996;7:3087-90
49. Lewis LR, Scheneider FH, Robins RK. Purine nucleosides. II. The preparation of 6-substituted 9-(tetrahydro-2-furyl) purines and 6-substituted 9-(tetrahydro-2-thienyl)purines as models of purine deoxynucleosides. J Org Chem 1961;26:3837-42
50. Ghassemi S, Fuchs K. Alternative method of Boc-removal from sulfamide using silica-phenyl sulfonic acid in conjunction with microwave heating. Mol Divers 2005;9:295-9
51. Jacob AM, Moody CJ. Microwave-assisted combined Mitsunobu reaction-Claisen rearrangement and microwave-assisted phenol oxidation: rapid synthesis of 2,6-disubstituted 1,4-benzoquinone natural products. Tetrahedron Lett 2005;46:8823-5
52. Palladino A, Mugnaini C, Botta M, Corelli F. A new linker for anchoring/ masking primary amines an solid support. Org Lett 2005;7:565-8
53. McErlean CSP, Moody CJ. First synthesis of N-(3-carboxylpropyl)-5-amino-2-hydroxy-3-tridecyl-1, 4-benzoquinone, an unusual quinone isolated from embelia ribes. J Org Chem 2007; published on line 14 November 2007, 10.1021/jo702101w S0022-3263(70)02101-1
54. Desai B, Dallinger D, Kapper CO. Microwave-assisted solution phase synthesis of dihydropyrimidine C5 amides and esters. Tetrahedron 2006;62:4651-64